A Look into America’s Struggle with Healthcare Access and Insurance Coverage

This article was published on Arbona Health Hub Volume 1 Issue 2 (ISSN: 3065-5544). I thought it would be interesting to dive into the current state of insurance practices in the United States and the resounding negative sentiments toward the US healthcare system. With the United States spending the most per capita on healthcare and… Read More A Look into America’s Struggle with Healthcare Access and Insurance Coverage

Private Equity: The Increased Commercialization of Healthcare

This article was published on Arbona Health Hub Volume 1 Issue 1 (ISSN: 3065-5544). Private equity (PE) ownership has been a growing trend in the healthcare industry, raising questions about its implications for patient care and the healthcare system as a whole. Private equity in healthcare is a form of for-profit ownership of hospitals/medical centers/nursing… Read More Private Equity: The Increased Commercialization of Healthcare

The Hurdles With Accessible Mental Health Care

Background The Mental Health Parity and Addiction Equity Act (MHPAEA), passed in 2008 by Congress, is considered a major victory for access to mental health and substance use disorder treatment (MH/SUD). The law requires commercial health plans to provide mental health and substance use treatment “no more restrictive” than coverage for all other physical health/medical/surgical… Read More The Hurdles With Accessible Mental Health Care

Should You Go Plant-Based? A Look Into the Benefits of Eating Plant-Based Diets

Hello! Welcome to learning about plant-based eating! I have an interest in understanding how nutrition connects our mind and body, and what better way to dive deeper into this than reviewing the benefits of plant-based eating. I hope to enlighten you with this short review on the holistic advantages of eating plant-based, and how amazing… Read More Should You Go Plant-Based? A Look Into the Benefits of Eating Plant-Based Diets

Cosmetic Use Of Ozempic On The Rise

Summary: The research study explores the growing public interest in the off-label use of Glucagon-like Peptide 1 (GLP-1) agonists, particularly Ozempic, for cosmetic weight loss. Using Google Trends, the study reveals a significant surge in relative search volume (RSV) for “Ozempic”, “Wegovy”, and “Mounjaro” over a 5-year period, indicating a heightened curiosity and potential demand… Read More Cosmetic Use Of Ozempic On The Rise